KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Current Assets (2018 - 2025)

Historic Current Assets for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $18.5 billion.

  • BioNTech SE's Current Assets fell 884.13% to $18.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 billion, marking a year-over-year decrease of 884.13%. This contributed to the annual value of $20.1 billion for FY2024, which is 436.39% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Current Assets is $18.5 billion, which was down 884.13% from $18.0 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Current Assets registered a high of $22.4 billion during Q4 2022, and its lowest value of $4.3 billion during Q1 2021.
  • For the 5-year period, BioNTech SE's Current Assets averaged around $18.5 billion, with its median value being $20.1 billion (2024).
  • In the last 5 years, BioNTech SE's Current Assets surged by 138559.23% in 2021 and then tumbled by 1720.74% in 2025.
  • Over the past 5 years, BioNTech SE's Current Assets (Quarter) stood at $17.2 billion in 2021, then rose by 29.72% to $22.4 billion in 2022, then fell by 6.06% to $21.0 billion in 2023, then dropped by 4.36% to $20.1 billion in 2024, then fell by 7.9% to $18.5 billion in 2025.
  • Its last three reported values are $18.5 billion in Q3 2025, $18.0 billion for Q2 2025, and $16.4 billion during Q1 2025.